Alerts will be sent to your verified email
Verify Email
ANG
|
ANG Lifesciences
|
Bacil Pharma
|
Bandaram Pharma Pack
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.03 % | 0.32 % | 5.64 % |
|
5yr average Equity Multiplier
|
3.3 | 1.36 | 4.09 |
|
5yr Average Asset Turnover Ratio
|
0.77 | 0.0 | 0.98 |
|
5yr Avg Net Profit Margin
|
-2.26 % | 0.0 | 1.46 % |
|
Price to Book
|
1.06 | 2.3 | 2.05 |
|
P/E
|
0.0 | 36.69 | 121.67 |
|
5yr Avg Cash Conversion Cycle
|
70.26 Days | 0.0 | 185.52 Days |
|
Inventory Days
|
107.37 Days | 0.0 | 58.64 Days |
|
Days Receivable
|
274.82 Days | 0.0 | 164.3 Days |
|
Days Payable
|
235.98 Days | 0.0 | 29.07 Days |
|
5yr Average Interest Coverage Ratio
|
1.81 | -943.72 | 2.12 |
|
5yr Avg ROCE
|
15.08 % | -75.56 % | 8.53 % |
|
5yr Avg Operating Profit Margin
|
7.68 % | 0.0 | 7.35 % |
|
5 yr average Debt to Equity
|
0.97 | 0.05 | 2.33 |
|
5yr CAGR Net Profit
|
n/a | n/a | 16.17 % |
|
5yr Average Return on Assets
|
1.04 % | -70.2 % | 1.43 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.6 % | 0.0 | 62.66 % |
|
Share Pledged by Promoters
|
44.88 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -42.67 % | -12.34 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
ANG Lifesciences
|
Bacil Pharma
|
Bandaram Pharma Pack
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|